Alisa Lask Net Worth & Insider Trades

Alisa Lask - Director, Nephros Inc

As of January 9, 2023

What is Alisa Lask's Net Worth?

The current estimated net worth of Nephros Inc's Director, Alisa Lask, is estimated to be about $99.41K . Alisa Lask owns about 250 units of Nephros Inc common stock. In the last 4 years at Nephros Inc, Alisa Lask has sold an estimated value of $0 worth.

What is Alisa Lask's Past Insider Trading?

Alisa Lask's largest purchase order was 250 units , worth over $1.61K on September 13, 2019. In total, Alisa Lask has made about 6 transactions over 4 years of their time at Nephros Inc. Alisa Lask usually trades in January and December, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Alisa Lask's' Mailing Address?

  • Mailing address is C/o 380 Lackawanna Place South Orange NJ 07079 NJ

Nephros Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Andrew Astor 2020 $309,006 - - $680,547 - $989,553
Andrew Astor 2019 $295,108 $51,644 $58,687 $114,689 $8,853 $528,981
Daron Evans 2020 $300,177 - - - - $300.177
Daron Evans 2019 $350,000 $70,000 $79,547 $114,689 $10,500 $624,736
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1196298/000149315221008202/formdef14a.htm

What are Nephros Inc's Past Insider Trades?

Nephros Inc's most recent insider trade came on August 23, 2021 by Wesley Lobo Pursuant To Power of Attorney Previously Filed. who bought 1,000 units worth $7.92K . In the last 12 years, insiders at Nephros Inc have sold an estimated value of $1.05M and bought an estimated value of $2.04M worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Daron Evans, CEO Specialty Renal Product,  Andrew Astor, President,  and Arthur H Amron, Director .

NEPHROS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...